{{Rsnum
|rsid=1167846
|Gene=IL20RA
|Chromosome=6
|position=137022583
|Orientation=plus
|GMAF=0.326
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IL20RA
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 56.9 | 36.9 | 6.2
| HCB | 82.2 | 15.6 | 2.2
| JPT | 71.1 | 28.9 | 0.0
| YRI | 1.7 | 28.3 | 70.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 82.2 | 15.6 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}haplotype CCG ([[rs1184860]], [[rs1167846]], [[rs1167849]]) is significantly associated with [[psoriasis]] (OR 3.14, 95% CI 1.61-6.14), whereas the TTG haplotype had a protective effect (OR 0.20, 95% CI 0.07-0.55).

{{PMID Auto
|PMID=18480827
|Title=Association analysis of IL20RA and IL20RB genes in psoriasis.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}